Advocacy intelligence hub — real-time data for patient organizations
Lupron Depot-Ped: FDA approved
treatment of pediatric patients with central precocious puberty (CPP)
Triptodur: FDA approved
Treatment of pediatric patients 2 years of age and older with central precocious puberty
Supprelin LA: FDA approved
Treatment of central precocious puberty
Synarel Nasal Solution: FDA approved
Treatment of central precocious puberty (gonadotropin-dependent precocious puberty) in children of both sexes.
Supprelin Injection: FDA approved
Treatment of central precocious puberty.
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Open now
Copay cards
Copay Assistance3
Lupron Depot
AbbVie Inc.
Supprelin Injection
Roberts Pharmaceutical Corp.
Synarel Nasal Solution
Syntex (USA), Inc.
Lupron Depot-Ped
(Leuprolide acetate)Orphan drugAbbVie Endocrine Inc.
12.1 Mechanism of Action Leuprolide acetate, a GnRH agonist, acts as a potent inhibitor of gonadotropin secretion (LH and follicle stimulating hormone...
Triptodur
(triptorelin pamoate)Orphan drugArbor Pharmaceuticals, LLC
12.1 Mechanism of Action Triptorelin is a GnRH agonist.
Supprelin LA
(Histrelin)Orphan drugEndo Pharmaceuticals Solutions, Inc.
12.1 Mechanism of Action SUPPRELIN LA is a GnRH agonist and an inhibitor of gonadotropin secretion when given continuously. It delivers approximately ...
Synarel Nasal Solution
(Nafarelin acetate)Orphan drugSyntex (USA), Inc.
Supprelin Injection
(Histrelin acetate)Orphan drugRoberts Pharmaceutical Corp.
12.1 Mechanism of Action SUPPRELIN LA is a GnRH agonist and an inhibitor of gonadotropin secretion when given continuously. It delivers approximately ...